Skip to Content Skip to Content
  • Campus & Community
  • The research landscape is changing. Penn Forward’s Research Strategy co-chairs are ready to adapt

    As co-chairs of the Penn Forward Research Strategy and Financing working group, David Meaney, vice provost for research, and Michael Ostap, chief scientific officer of the Perelman School of Medicine, are collaborating to expand Penn’s research impact.

    5 min. read

    Michael Ostap, left, with David Meaney outdoors in front of a limestone building with autumn trees, wearing suits and ties.
    Michael Ostap, left, with David Meaney on College Green. Ostap and Meaney are co-chairs of Penn Forward’s Research Strategy and Financing working group.

    Recent Articles

  • More Articles
  • The Fed explained: What it does and why it matters
    Photo of the Federal Reserve facade

    (Image: Lance Nelson)

    The Fed explained: What it does and why it matters

    Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy

    May 13, 2026

    Fighting oral cancer with bioengineered chewing gum
    A latex-gloved hand hoding a petri dish of medical chewing gum.

    A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

    (Image: Kevin Monko/Penn Dental Medicine)

    Fighting oral cancer with bioengineered chewing gum

    Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

    Apr 20, 2026